age_at_diagnosis,chemotherapy,cohort,neoplasm_histologic_grade,hormone_therapy,lymph_nodes_examined_positive,mutation_count,nottingham_prognostic_index,overall_survival_months,radio_therapy,tumor_size,tumor_stage,myc,hsd17b11,spry2,syne1,lama2,abcb1,abcc1,rps6,mmp3,mmp7,pdgfra,kit,mapk14,casp6,casp8,stat5a,e2f2,folr2,fgf1,rassf1,mmp11,type_of_breast_surgery_BREAST CONSERVING,type_of_breast_surgery_MASTECTOMY,type_of_breast_surgery_nan,cancer_type_Breast Cancer,cancer_type_Breast Sarcoma,cancer_type_nan,cancer_type_detailed_Breast,cancer_type_detailed_Breast Invasive Ductal Carcinoma,cancer_type_detailed_Breast Invasive Lobular Carcinoma,cancer_type_detailed_Breast Invasive Mixed Mucinous Carcinoma,cancer_type_detailed_Breast Mixed Ductal and Lobular Carcinoma,cancer_type_detailed_Metaplastic Breast Cancer,cancer_type_detailed_nan,cellularity_High,cellularity_Low,cellularity_Moderate,cellularity_nan,pam50_+_claudin-low_subtype_Basal,pam50_+_claudin-low_subtype_Her2,pam50_+_claudin-low_subtype_LumA,pam50_+_claudin-low_subtype_LumB,pam50_+_claudin-low_subtype_NC,pam50_+_claudin-low_subtype_Normal,pam50_+_claudin-low_subtype_claudin-low,pam50_+_claudin-low_subtype_nan,er_status_measured_by_ihc_Negative,er_status_measured_by_ihc_Positve,er_status_measured_by_ihc_nan,er_status_Negative,er_status_Positive,er_status_nan,her2_status_measured_by_snp6_GAIN,her2_status_measured_by_snp6_LOSS,her2_status_measured_by_snp6_NEUTRAL,her2_status_measured_by_snp6_UNDEF,her2_status_measured_by_snp6_nan,her2_status_Negative,her2_status_Positive,her2_status_nan,tumor_other_histologic_subtype_Ductal NST,tumor_other_histologic_subtype_Lobular,tumor_other_histologic_subtype_Medullary,tumor_other_histologic_subtype_Metaplastic,tumor_other_histologic_subtype_Mixed,tumor_other_histologic_subtype_Mucinous,tumor_other_histologic_subtype_Other,tumor_other_histologic_subtype_Tubular  cribriform,tumor_other_histologic_subtype_nan,inferred_menopausal_state_Post,inferred_menopausal_state_Pre,inferred_menopausal_state_nan,integrative_cluster_1,integrative_cluster_10,integrative_cluster_2,integrative_cluster_3,integrative_cluster_4ER+,integrative_cluster_4ER-,integrative_cluster_5,integrative_cluster_6,integrative_cluster_7,integrative_cluster_8,integrative_cluster_9,integrative_cluster_nan,primary_tumor_laterality_Left,primary_tumor_laterality_Right,primary_tumor_laterality_nan,oncotree_code_BREAST,oncotree_code_IDC,oncotree_code_ILC,oncotree_code_IMMC,oncotree_code_MBC,oncotree_code_MDLC,oncotree_code_nan,pr_status_Negative,pr_status_Positive,pr_status_nan,3-gene_classifier_subtype_ER+ HER2- High Prolif,3-gene_classifier_subtype_ER+ HER2- Low Prolif,3-gene_classifier_subtype_ER- HER2-,3-gene_classifier_subtype_HER2+,3-gene_classifier_subtype_nan
42.9,1,2,3,0,2,5,5.046,259.7666667,1,23,2,0.5063,1.9352,0.976,-0.5694,0.5294,2.1131,-0.9781,0.5276,0.3343,1.1665,0.7985,1.014,0.8887,-1.1493,0.8122,1.6359,-0.1372,1.8507,-1.1782,1.9114,-1.3784,0,1,0,1,0,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,0,0,0,1,0,1,0,0,1,0,0,0,0,1,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,1,0,0,0,0,0,0,1
